The Directorate of Revenue Intelligence (DRI) has begun investigations into 28 companies that have wrongly claimed services export benefits, according to the agency, which has issued notices to them. They include a New York Stock Exchange-listed pharma company focussing on livestock and pets that has an R&D centre in India, an IT product company and a few five-star hotels.